Inventor · disambiguated record
Gera Neufeld
Also filed as: NEUFELD GERA
16 granted patents·11 pending applications·159 citations·filing 1997–2021
93Inventor score
Files withNEUFELD GERA9TECHNION RES & DEV FOUNDATION7TECHNION RES & DEV CO LTD3RAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES2MEDICAL RES & DEVELOPMENT FUND FOR HEALTH SERVICES BNAI ZION MEDICAL CENTER1
Top patents by PatentIndex Score
27 records- 0193US8168180B2Methods and compositions for modulating angiogenesisNEUFELD GERA·Filed 2009·Granted May 1, 2012·26 cites·13 claims
- 0290US8163494B2Method for assessing metastatic properties of breast cancerNEUFELD GERA·Filed 2003·Granted Apr 24, 2012·23 cites·32 claims
- 0386US8815823B2Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsNEUFELD GERA·Filed 2012·Granted Aug 26, 2014·7 cites·19 claims
- 0482US8389709B2Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosisNEUFELD GERA·Filed 2008·Granted Mar 5, 2013·4 cites·13 claims
- 0581US6013780AVEGF145 expression vectorsTECHNION RESEARCH & DEV CO LTD·Filed 1997·Granted Jan 11, 2000·58 cites·10 claims
- 0679US8815824B2Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosisNEUFELD GERA·Filed 2012·Granted Aug 26, 2014·3 cites·12 claims
- 0777US9255271B2Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosisTECHNION RES & DEV FOUNDATION·Filed 2014·Granted Feb 9, 2016·2 cites·12 claims
- 0874US6583276B1Angiogenic factors and use thereof in treating cardiovascular diseaseTECHNION RES AND DEV CO LTD·Filed 1998·Granted Jun 24, 2003·24 cites·6 claims
- 0971US2014302499A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsTECHNION RES & DEV FOUNDATION·Filed 2014·Application pending·0 cites
- 1070US9896490B2Semaphorin 3C variants, compositions comprising said variants and methods of use thereofRAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES·Filed 2014·Granted Feb 20, 2018·1 cites·25 claims
- 1170US2009291891A1VEGF variant that lacks VEGFR-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosisTECHNION RES & DEV·Filed 2009·Application pending·0 cites
- 1269US8088735B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofNEUFELD GERA·Filed 2008·Granted Jan 3, 2012·1 cites·9 claims
- 1367US8513194B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofNEUFELD GERA·Filed 2011·Granted Aug 20, 2013·1 cites·6 claims
- 1465US2019040470A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsTECHNION RES & DEV FOUNDATION·Filed 2018·Application pending·0 cites
- 1564US2012202206A1Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumorsNEUFELD GERA·Filed 2012·Application pending·0 cites
- 1660US2006252919A1Vegf variant that lacks vegfr-1 binding activity and its use in promotion of re-endothelization and prevention of in-stent restenosisTECHNION RES & DEV FOUNDATION·Filed 2003·Application pending·0 cites
- 1760US2003114410A1Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosisTECHNION RES & DEV FOUNDATION·Filed 2002·Application pending·0 cites
- 1858US9617347B2Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosisTECHNION RES & DEV FOUNDATION·Filed 2016·Granted Apr 11, 2017·0 cites·1 claims
- 1954US9808506B2Compositions comprising semaphorins for the treatment of cancer and methods of selection thereofRAPPAPORT FAMILY INST FOR RES IN THE MEDICAL SCIENCES·Filed 2015·Granted Nov 7, 2017·0 cites·15 claims
- 2054US9155781B2Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereofRAPPAPORT FAMILY INST FOR RES·Filed 2013·Granted Oct 13, 2015·0 cites·8 claims
- 2153US2018055907A1Compositions comprising semaphorins for the treatment of cancer and methods of selection thereofRAPPAPORT FAMILY INSTITUTE FOR RES IN THE MEDICAL SCIENCES·Filed 2017·Application pending·0 cites
- 2251US6589782B1Angiogenic factor and use thereof in treating cardiovascular diseaseTECHNION RES & DEV CO LTD·Filed 1999·Granted Jul 8, 2003·9 cites·5 claims
- 2350US2023272020A1Modified semaphorin 3a, compositions comprising the same and uses thereofMEDICAL RES & DEVELOPMENT FUND FOR HEALTH SERVICES BNAI ZION MEDICAL CENTER·Filed 2021·Application pending·0 cites
- 2445US2003165467A1Angiogenic factor and use thereof in treating cardiovascular diseaseTECHNION RES & DEV CO LTD·Filed 2002·Application pending·0 cites
- 2539US2006084622A1Angiogenic factor and use thereof in treating cardiovascular diseaseTECHNION RES & DEV CO LTD·Filed 2005·Application pending·0 cites
- 2638US10561707B2Semaphorin 3C variants, compositions comprising said variants and methods of use thereof in treating eye diseasesTECHNION RES & DEV FOUNDATION·Filed 2017·Granted Feb 18, 2020·0 cites·20 claims
- 2737US2013330349A1High affinity molecules capable of binding a type a plexin receptor and uses of sameNEUFELD GERA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gera Neufeld files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →